Indivior Pharmaceuticals, Inc. (INDV)
36.18
-0.69
(-1.87%)
USD |
NASDAQ |
Aug 24, 16:00
36.18
0.00 (0.00%)
After-Hours: 19:58
Indivior Pharmaceuticals Debt to Equity Ratio : -2.447 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.447 |
| March 31, 2026 | -3.535 |
| December 31, 2025 | -3.582 |
| September 30, 2025 | -1.720 |
| June 30, 2025 | -1.424 |
| March 31, 2025 | -1.298 |
| December 31, 2024 | -1.113 |
| September 30, 2024 | -1.701 |
| June 30, 2024 | -2.322 |
| March 31, 2024 | 27.90 |
| December 31, 2023 | |
| September 30, 2023 | -11.54 |
| June 30, 2023 | 2.402 |
| March 31, 2023 | 3.875 |
| December 31, 2022 | 5.431 |
| September 30, 2022 | 1.216 |
| June 30, 2022 | 1.217 |
| March 31, 2022 | 1.216 |
| December 31, 2021 | 1.409 |
| September 30, 2021 | 1.789 |
| June 30, 2021 | 1.245 |
| March 31, 2021 | 1.720 |
| December 31, 2020 | 3.476 |
| Date | Value |
|---|---|
| September 30, 2020 | 3.538 |
| June 30, 2020 | 4.897 |
| March 31, 2020 | 7.308 |
| December 31, 2019 | 1.402 |
| September 30, 2019 | 1.159 |
| June 30, 2019 | 1.439 |
| March 31, 2019 | 2.233 |
| December 31, 2018 | 3.652 |
| September 30, 2018 | 6.854 |
| June 30, 2018 | -11.09 |
| March 31, 2018 | -4.782 |
| December 31, 2017 | -2.374 |
| September 30, 2017 | -6.351 |
| June 30, 2017 | -3.616 |
| March 31, 2017 | -2.483 |
| December 31, 2016 | -1.814 |
| September 30, 2016 | -1.429 |
| June 30, 2016 | -3.299 |
| March 31, 2016 | -2.583 |
| December 31, 2015 | -2.168 |
| September 30, 2015 | -2.384 |
| June 30, 2015 | -2.102 |
| March 31, 2015 | -1.711 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Supernus Pharmaceuticals, Inc. | 0.039 |
| Liquidia Corp. | 0.9374 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Amneal Pharmaceuticals, Inc. | 84.54 |
| Prestige Consumer Healthcare, Inc. | 1.079 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.233B |
| Total Liabilities (Quarterly) | 1.441B |
| Shareholders Equity (Quarterly) | -208.00M |
| Current Ratio | 0.8353 |
| Net Debt Paydown Yield | -0.57% |